Clinical trials
Active, not recruiting Carcinoma, Non-Small-Cell Lung trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
92 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 10 |
| 2020 | 12 |
| 2021 | 7 |
| 2022 | 19 |
| 2023 | 16 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 92 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 12 |
| Janssen Research & Development, LLC | 7 |
| Eli Lilly and Company | 5 |
| Hoffmann-La Roche | 5 |
| Merck Sharp & Dohme LLC | 5 |
| Daiichi Sankyo | 4 |
| Gilead Sciences | 4 |
| Seagen, a wholly owned subsidiary of Pfizer | 4 |
| GlaxoSmithKline | 3 |
| ArriVent BioPharma, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 92 |
| Lung Neoplasms | 11 |
| Melanoma | 10 |
| Colorectal Neoplasms | 9 |
| Neoplasm Metastasis | 8 |
| Neoplasms | 8 |
| Ovarian Neoplasms | 8 |
| Breast Neoplasms | 7 |
| Head and Neck Neoplasms | 7 |
| Endometrial Neoplasms | 6 |
Trials
Showing 1 to 25 of 92. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.